Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy.
Ilie SM, Briot N, Constatin G, Ilie A, Beltjens F, Ladoire S, Desmoulins I, Hennequin A, Bertaut A, Coutant C, Causeret S, Ghozali N, Coudert B, Arnould L.
Ilie SM, et al. Among authors: ilie a.
Front Oncol. 2024 Jan 10;13:1309890. doi: 10.3389/fonc.2023.1309890. eCollection 2023.
Front Oncol. 2024.
PMID: 38273853
Free PMC article.